Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Drug Interactions Between Lopinavir/Ritonavir and Oral or Patch Contraceptives in HIV Infected Women

ClinicalTrials.gov ID: NCT00125983

Public ClinicalTrials.gov record NCT00125983. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 24, 2026, 12:39 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Pharmacokinetic Study of the Transdermal Contraceptive System and Oral Contraceptive in HIV-1 Infected Women on Lopinavir/Ritonavir

Study identification

NCT ID
NCT00125983
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Enrollment
32 participants

Conditions and interventions

Interventions

  • Lopinavir/ritonavir Drug
  • Ortho Novum 1/35 Drug
  • Ortho Evra Drug

Drug

Eligibility (public fields only)

Age range
13 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Dec 31, 2006
Last update posted
Oct 31, 2021

Ends 2007

United States locations

U.S. sites
8
U.S. states
6
U.S. cities
6
Facility City State ZIP Site status
USC CRS Los Angeles California 90033-1079
Usc La Nichd Crs Los Angeles California 90033
University of Colorado Hospital CRS Aurora Colorado
Univ. of Hawaii at Manoa, Leahi Hosp. Honolulu Hawaii 96816-2396
Indiana Univ. School of Medicine, Infectious Disease Research Clinic Indianapolis Indiana 46202-5250
Beth Israel Med. Ctr., ACTU New York New York 10003
Weill Med. College of Cornell Univ., The Cornell CTU New York New York 10021
Pitt CRS Pittsburgh Pennsylvania

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00125983, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 31, 2021 · Synced Jul 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00125983 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →